How to effectively utilize genetic testing in the care of children with cardiomyopathies

被引:5
作者
Russell, Mark [1 ]
Roberts, Amy E. [2 ,3 ]
Abrams, Dominic J. [4 ]
Murphy, Anne M. [5 ]
Towbin, Jeffrey A. [6 ]
Chung, Wendy K. [7 ,8 ]
机构
[1] Univ Michigan, Dept Pediat & Communicable Dis, Div Pediat Cardiol, Ann Arbor, MI 48109 USA
[2] Boston Childrens Hosp, Dept Med, Div Genet, Boston, MA USA
[3] Boston Childrens Hosp, Dept Cardiol, Div Genet, Boston, MA USA
[4] Boston Childrens Hosp, Dept Med, Change Div Cardiol, Boston, MA USA
[5] Johns Hopkins Univ, Dept Pediat, Div Cardiol, Baltimore, MD 21218 USA
[6] Cincinnati Childrens Hosp, Med Ctr, Heart Inst, Cincinnati, OH USA
[7] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10027 USA
[8] Columbia Univ, Med Ctr, Dept Med, New York, NY USA
关键词
Genetic; Genetic testing; Pediatric cardiomyopathy;
D O I
10.1016/j.ppedcard.2015.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiomyopathy (CM) in children shares some features with cardiomyopathy in adults but also has many important unique features. Heretofore, genetic testing panels, testing strategies, and treatment recommendations have largely been based on studies in adult populations. In general, CMs in children are much more likely to be genetic and to have extracardiac manifestations that should be medically addressed. Therefore, genetic testing in children with CM is an essential part of their initial evaluation and the ongoing care of the child and family. CMs in children are more genetically heterogeneous, and many of the genes that are rare causes of CM in children are not currently included in testing panels, and future genetic testing is likely to increasingly utilize more comprehensive approaches such as whole exome/whole genome sequencing with focused analysis of all the genes that can cause CM in children. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 83 条
[51]   PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY IN A GENERAL-POPULATION OF YOUNG-ADULTS - ECHOCARDIOGRAPHIC ANALYSIS OF 4111 SUBJECTS IN THE CARDIA STUDY [J].
MARON, BJ ;
GARDIN, JM ;
FLACK, JM ;
GIDDING, SS ;
KUROSAKI, TT ;
BILD, DE .
CIRCULATION, 1995, 92 (04) :785-789
[52]   SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism [J].
McNair, William P. ;
Sinagra, Gianfranco ;
Taylor, Matthew R. G. ;
Di Lenarda, Andrea ;
Ferguson, Debra A. ;
Salcedo, Ernesto E. ;
Slavov, Dobromir ;
Zhu, Xiao ;
Caldwell, John H. ;
Mestroni, Luisa .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (21) :2160-2168
[53]  
Mestroni L, 2013, DISCOV MED, V15, P43
[54]   Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations [J].
Mogensen, J ;
Kubo, T ;
Duque, M ;
Uribe, W ;
Shaw, A ;
Murphy, R ;
Gimeno, JR ;
Elliott, P ;
McKenna, WJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (02) :209-216
[55]   Genetic Evaluation of Dilated Cardiomyopathy [J].
Morales, Ana ;
Hershberger, Ray E. .
CURRENT CARDIOLOGY REPORTS, 2013, 15 (07)
[56]   Primary LAMP-2 deficiency causes X-linked vacoular cardiomyopathy and myopathy (Danon disease) [J].
Nishino I. ;
Fu J. ;
Tanji K. ;
Yamada T. ;
Shimojo S. ;
Koori T. ;
Mora M. ;
Riggs J.E. ;
Oh S.J. ;
Koga Y. ;
Sue C.M. ;
Yamamoto A. ;
Murakami N. ;
Shanske S. ;
Byrne E. ;
Bonilla E. ;
Honaka I. ;
DiMauro S. ;
Hirano M. .
Nature, 2000, 406 (6798) :906-910
[57]   Assessment of LMNA Copy Number Variation in 58 Probands with Dilated Cardiomyopathy [J].
Norton, Nadine ;
Siegfried, Jill D. ;
Li, Duanxiang ;
Hershberger, Ray E. .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2011, 4 (05) :351-352
[58]  
Pauli RM, 1999, AM J MED GENET, V85, P419, DOI 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO
[59]  
2-S
[60]   Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene [J].
Peddy, SB ;
Vricella, LA ;
Crosson, JE ;
Oswald, GL ;
Cohn, RD ;
Cameron, DE ;
Valle, D ;
Loeys, BL .
PEDIATRICS, 2006, 117 (05) :1830-1833